Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.
ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...
Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Hearing the word cancer changes the air in the room, even if you suspected something was wrong. You may feel numb. Panicked.
CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...
Dr. William A. Hall sat down with CURE for a live interview at the 2026 ASCO Gastrointestinal Cancers Symposium to discuss ...
Dr. William A. Hall discusses overtreatment in gastrointestinal cancer care and how AI-driven response assessment is shaping personalized treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback